Showing results (1-10 of 56) with videos related to
Sort By:
Pageof 6
Journal of Clinical Medicine|June 12, 2026
Note-Level Phenotyping of Multiple-Sclerosis Notes by a Large Language Model Achieves near Human-Level AgreementDaniel B Hier, Pavankumar Y Srinivasula, Michael D CarrithersBrain Sciences|July 28, 2026
Phenotypic Diversity in Multiple Sclerosis Can Be Represented by Four Additive Symptom ModulesDaniel B Hier, Pavankumar Y Srinivasula, Michael D CarrithersJournal of Clinical Medicine|July 15, 2026
Distinct Regulatory DNA Methylation Signatures Across Multiple Sclerosis, Neuromyelitis Optica, and Neurological Post-Acute Sequelae of COVID-19Syed Ilyas Munzir, Daniel B Hier, Michael D CarrithersAnnual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Annual International Conference|March 5, 2025
High Throughput Phenotyping of Physician Notes with Large Language and Hybrid NLP ModelsSyed I Munzir, Daniel B Hier, Michael D CarrithersFrontiers in Digital Health|February 13, 2023
The visualization of Orphadata neurology phenotypesDaniel B Hier, Raghu Yelugam, Michael D Carrithers, et al.Frontiers in Digital Health|June 29, 2023
Inter-rater agreement for the annotation of neurologic signs and symptoms in electronic health recordsChelsea Oommen, Quentin Howlett-Prieto, Michael D Carrithers, et al.Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Annual International Conference|December 3, 2025
REMOTE: A Framework to Create Fast Healthcare Interoperability Resources (FHIR) from Unstructured Clinical DataDaniel B Hier, Michael D Carrithers, Thanh Son Do, et al.Frontiers in Digital Health|January 30, 2023
Subtypes of relapsing-remitting multiple sclerosis identified by network analysisQuentin Howlett-Prieto, Chelsea Oommen, Michael D Carrithers, et al.BMC Medical Informatics and Decision Making|December 8, 2025
A formal explanation space for the simultaneous clustering of neurologic diseases based on their signs and symptomsRaghu Yelugam, Daniel B Hier, Tayo Obafemi-Ajayi, et al.Current Pharmaceutical Biotechnology|February 21, 2012
Current Immunotherapy of Multiple Sclerosis and Future Challenges: Relevance of Immune-mediated RepairMichael D CarrithersPageof 6